GE HealthCare Technologies Inc. GEHC recently announced the launch of the Prostate Volume Assist (PVA) urology-based artificial intelligence (AI) software feature. This AI-powered software function ...

For prostate cancer patients with low-volume tumors and metastasis, the median overall survival was 37.13 months. Prostate cancer patients with metastatic disease and low-volume primary tumors appear ...

Whether the center was an academic setting or not had no bearing on results. High-volume radiation treatment facilities contribute to better survival outcomes in men with very high-risk prostate ...

Please provide your email address to receive an email when new articles are posted on . An AI model showed tumor size to be an independent risk factor for prostate cancer metastasis and recurrence. AI ...

Please provide your email address to receive an email when new articles are posted on . Men treated at high-volume centers had significantly longer OS than those treated at low-volume centers. The ...

Many men with low levels could be spared from invasive procedures and frequent testing ...

NEW YORK (Reuters Health) - Prostate size affects the technical difficulty of radical prostatectomy -- total surgical removal of the prostate gland as a treatment for prostate cancer -- but not the ...